A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73

Cited by (370)

Items 201–300 of 370

  1. Mass spectrometry: a technique of many faces
    Maya A. Olshina, Michal Sharon · 2016 · Quarterly Reviews of Biophysics
  2. Retraction Note: Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer
    Brad Patrick, Xueyi Gong, Anil K. Jaiswal · 2017 · Oncogene · Retracted
  3. Probing the cooperativity of Thermoplasma acidophilum proteasome core particle gating by NMR spectroscopy
    Rui Huang, F. Murillo Perez, Lewis E. Kay · 2017 · Proceedings of the National Academy of Sciences
  4. The Role of ZNF143 in Breast Cancer Cell Survival Through the NAD(P)H Quinone Dehydrogenase 1–p53–Beclin1 Axis Under Metabolic Stress
    A Rome Paek, Ji Young Mun, Mun Jeong Jo, Hyosun Choi, Yun Jeong Lee, Heesun Cheong, Jae‐Kyung Myung, Dongwan Hong, Jongkeun Park, Kyung‐Hee Kim et al. · 2019 · Cells
  5. NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma
    Eleni Frisira, Fatima Rashid, Swastina Nath Varma, Sara Badodi, Valentine Ayodele Benjamin-Ombo, David Michod, Maria Victoria Niklison-Chirou · 2019 · Cell Death and Disease
  6. A redox-mediated conformational change in NQO1 controls binding to microtubules and α-tubulin acetylation
    David M. Siegel, Stephanie M. Bersie, Peter S. Harris, Andrea Di Francesco, Michael Armstrong, Nichole A. Reisdorph, Michel Bernier, Rafael de Cabo, Kristofer S. Fritz, David Ross · 2020 · Redox Biology
  7. Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2
    Karen Ann Nolan, Matthew P. Humphries, John H. Barnes, Jeremy R. Doncaster, Mary C. Caraher, Nicola Tirelli, Richard A. Bryce, Roger Clive Whitehead, Ian James Stratford · 2009 · Bioorganic & Medicinal Chemistry
  8. Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis
    Qing Li, Ahmad Faisal Karim, Xuedong Ding, Biswajit Das, Curtis N. Dobrowolski, Richard M. Gibson, Miguel E. Quiñones‐Mateu, Jonathan Karn, Roxana E. Rojas · 2016 · Scientific Reports
  9. Ubiquitin-Dependent and Independent Proteasomal Degradation in Host-Pathogen Interactions
    Wojciech Białek, James F. Collawn, Rafał Bartoszewski · 2023 · Molecules
  10. Plastidial Starch Phosphorylase in Sweet Potato Roots Is Proteolytically Modified by Protein-Protein Interaction with the 20S Proteasome
    Yichen Lin, Han‐Min Chen, I-Min Chou, An-Na Chen, Chia-Pei Chen, Guang‐Huar Young, Chi‐Tsai Lin, Chiung‐Hsiang Cheng, Shih‐Chung Chang, Rong‐Huay Juang · 2012 · PLoS ONE
  11. NAD(P)H Quinone Oxidoreductase Protects TAp63γ from Proteasomal Degradation and Regulates TAp63γ-Dependent Growth Arrest
    Oshrat Hershkovitz‐Rokah, Ofer Shpilberg, Galit Granot · 2010 · PLoS ONE
  12. In Silico Screening Reveals Structurally Diverse, Nanomolar Inhibitors of NQO2 That Are Functionally Active in Cells and Can Modulate NF-κB Signaling
    Karen Ann Nolan, Mark S. Dunstan, Mary C. Caraher, Katherine Ann Scott, David Leys, Ian James Stratford · 2011 · Molecular Cancer Therapeutics
  13. Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease
    Taylor R. Church, Seth S. Margolis · 2025 · Frontiers in Cell and Developmental Biology
  14. Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer
    Brad Patrick, Xueyi Gong, Anil K. Jaiswal · 2010 · Oncogene · Retracted
  15. Direct proteasome binding and subsequent degradation of unspliced XBP‐1 prevent its intracellular aggregation
    Ami Navon, Ariel Gatushkin, Lior Zelcbuch, Shimon Shteingart, Marganit Farago, Rivka Hadar, Boaz Tirosh · 2009 · FEBS Letters
  16. Rab5a-mediated localization of claudin-1 is regulated by proteasomes in endothelial cells
    Machiko Asaka, Tetsuaki Hirase, Aiko Hashimoto, Koichi Node · 2010 · American Journal of Physiology-Cell Physiology
  17. The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer
    Jill Kolesar · 2011 · Oncology Reports
  18. Activation of PKCδ and p38δ MAPK during okadaic acid dependent keratinocyte apoptosis
    Catherine A. Kraft, Tatiana Efimova, Richard L. Eckert · 2007 · Archives of Dermatological Research
  19. Imidazoacridin-6-ones as novel inhibitors of the quinone oxidoreductase NQO2
    Karen Ann Nolan, Matthew P. Humphries, Richard A. Bryce, Ian James Stratford · 2010 · Bioorganic & Medicinal Chemistry Letters
  20. ACOX1 destabilizes p73 to suppress intrinsic apoptosis pathway and regulates sensitivity to doxorubicin in lymphoma cells
    Fei-Meng Zheng, Wangbing Chen, Tao Qin, Lina Lv, Bi Feng, Yan-Ling Lu, Zuo-Quan Li, Xiaochao Wang, Liju Tao, Hongwen Li et al. · 2019 · BMB Reports
  21. p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies
    Anđela Horvat, Ana Tadijan, Ignacija Vlašić, Neda Slade · 2021 · Cancers
  22. p73 gene in dopaminergic neurons is highly susceptible to manganese neurotoxicity
    Dong-Suk Kim, Huajun Jin, Vellareddy Anantharam, Richard Gordon, Arthi Kanthasamy, Anumantha G. Kanthasamy · 2016 · NeuroToxicology
  23. Enhanced glycometabolism as a mechanism of NQO1 potentiated growth of NSCLC revealed by metabolomic profiling
    Xuefang Cheng, Fang Liu, Huiying Liu, Guangji Wang, Haiping Hao · 2017 · Biochemical and Biophysical Research Communications
  24. Phosphorylation compromises FAD binding and intracellular stability of wild-type and cancer-associated NQO1: Insights into flavo-proteome stability
    Encarnación Medina‐Carmona, Bruno Rizzuti, Rubén Martín‐Escolano, Juan Luis Pacheco‐García, Noel Mesa‐Torres, José L. Neira, Rita Guzzi, Angel Luis Pey · 2018 · International Journal of Biological Macromolecules
  25. Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1
    EDUARDO C. SALIDO, David J. Timson, Isabel Betancor-Fernández, Rogelio Palomino‐Morales, Ernesto Anoz‐Carbonell, Juan Luis Pacheco‐García, Milagros Medina, Angel Luis Pey · 2022 · Journal of Personalized Medicine
  26. MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damage
    Giusy Di Conza, Francesca Mancini, Marianna Buttarelli, Alfredo Pontecorvi, Francesco Trimarchi, Fabiola Moretti · 2012 · Cell Cycle
  27. The Pancreatic and Duodenal Homeobox Protein PDX-1 Regulates the Ductal Specific Keratin 19 through the Degradation of MEIS1 and DNA Binding
    Johannes von Burstin, Maximilian Reichert, Melanie P. Wescott, Anil K. Rustgi · 2010 · PLoS ONE
  28. Proteasome regulates turnover of toxic human amylin in pancreatic cells
    Sanghamitra Singh, Saurabh Trikha, Anjali Angelika Sarkar, Aleksandar M. Jeremic · 2016 · Biochemical Journal
  29. Netrin-1 Induces Apoptosis in Human Cervical Tumor Cells via the TAp73α Tumor Suppressor
    Jean-Pierre Roperch, Karima El Ouadrani, Ann Hendrix, Shahin Emami, Olivier De Wever, Gerry Melino, Christian P. Gespach · 2008 · Cancer Research
  30. NAD (P)H dehydrogenase, quinone 1 ( NQO 1), protects melanin‐producing cells from cytotoxicity of rhododendrol
    Ayaka Okubo, Shinji Yasuhira, Masahiko Shibazaki, Kazuhiro Takahashi, Toshihide Akasaka, Tomoyuki Masuda, Chihaya Maesawa · 2016 · Pigment Cell & Melanoma Research
  31. Analysis of TAp73-Dependent Signaling via Omics Technologies
    Angelo D’Alessandro, Cristina Marrocco, Sara Rinalducci, Angelo Peschiaroli, Anna Maria Timperio, Lucilla Bongiorno‐Borbone, Alessandro Finazzi‐Agrò, Gerry Melino, Lello Zolla · 2013 · Journal of Proteome Research
  32. Biophysical and functional perturbation analyses at cancer-associated P187 and K240 sites of the multifunctional NADP(H):quinone oxidoreductase 1
    Angel Luis Pey · 2018 · International Journal of Biological Macromolecules
  33. Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1)
    Clare F. Megarity, Hoda Abdel‐Aal Bettley, Clare F. Megarity, Katherine Ann Scott, Roger Clive Whitehead, Thomas A. Jowitt, Aldo Gutiérrez, Richard A. Bryce, Karen Ann Nolan, Ian James Stratford et al. · 2019 · ChemBioChem
  34. Proteasome function and protein biosynthesis
    R. M. Vabulas · 2007 · Current opinion in clinical nutrition and metabolic care
  35. p73-Binding Partners and Their Functional Significance
    Toshinori Ozaki, Natsumi Kubo, Akira Nakagawara · 2010 · International Journal of Proteomics
  36. Structural dynamics and functional cooperativity of human NQO1 by ambient temperature serial crystallography and simulations
    Alice Grieco, Sergio Boneta, José Antonio Gavira, Angel Luis Pey, Shibom Basu, Julien Orlans, Daniele de Sanctis, Milagros Medina, Jose Manuel Martin-Garcia · 2024 · Protein Science
  37. Structural mass spectrometry approaches to study the 20S proteasome
    Gili Ben‐Nissan, Shay Vimer, Mark Tarnavsky, Michal Sharon · 2019 · Methods in enzymology on CD-ROM/Methods in enzymology
  38. The Origin and Role of MHC Class I-Associated Self-Peptides
    Claude Perreault · 2010 · Progress in molecular biology and translational science
  39. Recent advances in drug repositioning and rediscovery for different therapeutic activities utilizing updated technological approaches
    Eman Samir Nossier, Manal M. Anwar, Mohamed Ayman El‐Zahabi · 2025 · Molecular Diversity
  40. Transforming iodoquinol into broad spectrum anti-tumor leads: Repurposing to modulate redox homeostasis
    Ibrahim Chaaban, Haidy Hafez, Ibrahim AlZaim, Cynthia Tannous, Hanan M. Ragab, Aly A. B. Hazzaa, Salma Ketat, Asser I. Ghoneim, Mohamed Alaa Katary, Mohammad Mahmoud Abd-Alhaseeb et al. · 2021 · Bioorganic Chemistry
  41. The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells
    Tueanjai Khunluck, Veerapol Kukongviriyapan, Laddawan Senggunprai, Wutthipong Duangarsong, Auemduan Prawan · 2018 · Integrative Cancer Therapies
  42. SAMD4B, a novel SAM-containing protein, inhibits AP-1-, p53- and p21-mediated transcriptional activity
    Na Luo, Li Guan, Yongqing Li, Xiongwei Fan, Yuequn Wang, Xiangli Ye, Xiaoyan Mo, Junmei Zhou, Wuzhou Yuan, Ming Tan et al. · 2010 · BMB Reports
  43. Inhibition of tumor suppressor p73 by nerve growth factor receptor via chaperone-mediated autophagy
    Daniel Nguyen, KUN YU YANG, Lucia J. Chiao, Yun Deng, Xiang Yu Zhou, Zhen Zhang, Shelya X. Zeng, Hua Lu · 2020 · Journal of Molecular Cell Biology
  44. Relationship between regulatory pattern of gene expression level and gene function
    Masayo Inoue, Katsuhisa Horimoto · 2017 · PLoS ONE
  45. Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in Cancer
    Isabel Betancor-Fernández, David J. Timson, EDUARDO C. SALIDO, Angel Luis Pey · 2017 · Handbook of experimental pharmacology
  46. Ubiquitin-independent protein degradation in proteasomes
    О.А. Бунеева, A. E. Medvedev · 2018 · Biomeditsinskaya Khimiya
  47. Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer
    Brad Patrick, Anil K. Jaiswal · 2012 · Oncogene · Retracted
  48. A novel role of proteasomal β1 subunit in tumorigenesis
    Fuqiang Yuan, Yana Ma, Pan You, Wenbo Lin, Haojie Lu, Yinhua Yu, Xiaomin Wang, Jie Jiang, Pengyuan Yang, Qilin Ma et al. · 2013 · Bioscience Reports
  49. Retraction Note: Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer
    Brad Patrick, Anil K. Jaiswal · 2017 · Oncogene · Retracted
  50. Involvement of the oncogenic small nucleolar RNA SNORA24 in regulation of p53 stability in colorectal cancer
    Liping Shen, Chuxian Lin, Wenqing Lü, Junyan He, Qi Wang, Yujv Huang, Xiaofei Zheng, Zhidong Wang · 2022 · Cell Biology and Toxicology
  51. NAD(P)H:quinone Oxidoreductase 1 (NQO1) Competes with 20S Proteasome for Binding with C/EBPα Leading to Its Stabilization and Protection against Radiation-induced Myeloproliferative Disease
    Junkang Xu, Anil K. Jaiswal · 2012 · Journal of Biological Chemistry · Retracted
  52. Activation of NQO1 in NQO1*2 polymorphic human leukemic HL-60 cells by diet-derived sulforaphane
    JOSEPH M. WU, Ardalan Oraee, Barbara B. Doonan, John T. Pinto, Tze‐chen Hsieh · 2015 · Experimental Hematology and Oncology
  53. NQO1 regulates mitotic progression and response to mitotic stress through modulating SIRT2 activity
    Hong-Jun Kang, Ha Yong Song, Mohamed A. H. Ahmed, Yang Guo, Mingming Zhang, Chuyu Chen, Massimo Cristofanilli, Dai Horiuchi, Athanassios Vassilopoulos · 2018 · Free Radical Biology and Medicine
  54. Hydroxydibenzoylmethane induces apoptosis through repressing ornithine decarboxylase in human promyelocytic leukemia HL-60 cells
    Ming-Fu Wang, Ya-Fan Liao, Ying-Cheng Hung, Chih‐Li Lin, Tzyh‐Chyuan Hour, Ko-Huang Lue, Hui‐Chih Hung, Guang‐Yaw Liu · 2011 · Experimental & Molecular Medicine
  55. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation
    Roland Hjerpe, Fabienne Aillet, Fernando Lopitz‐Otsoa, Valérie Lang, Mónica Torres-Ramos, Rosa Farrás, Ronald T. Hay, Manuel S. Rodríguez · 2010 · The International Journal of Biochemistry & Cell Biology
  56. Posttranslational regulation of CYP2J2 by nitric oxide
    Ji Won Park, Choon‐Myung Lee, Joan S Cheng, Edward T. Morgan · 2018 · Free Radical Biology and Medicine
  57. Protein degradation profile reveals dynamic nature of 20S proteasome small molecule stimulation
    Rachel A. Coleman, Rodrigo Mohallem, Uma K. Aryal, Darci Jones Trader · 2021 · RSC Chemical Biology
  58. Ricin B Chain Targeted to the Endoplasmic Reticulum of Tobacco Protoplasts Is Degraded by a CDC48- and Vacuole-independent Mechanism*
    Kerry L. Chamberlain, Richard Scott Marshall, Nicholas A. Jolliffe, Lorenzo Frigerio, Aldo Ceriotti, Janet M. Lord, Lynne M. Roberts · 2008 · Journal of Biological Chemistry
  59. Ltbp4 regulates Pdgfrβ expression via TGFβ-dependent modulation of Nrf2 transcription factor function
    Ana Tomasovic, Nina Kurrle, Frank Wempe, Silke De-Zolt, Susan Scheibe, Katri M. Koli, Martin Serchinger, Frank Schnütgen, Duran Sürün, Anja Sterner‐Kock et al. · 2016 · Matrix Biology
  60. Ubiquitination-dependent degradation of p73 by the mitochondrial E3 ubiquitin ligase Hades
    Bumki Min, Jiwon Ryu, Seung‐Wook Chi, Gwan‐Su Yi · 2015 · Biochemical and Biophysical Research Communications
  61. A small molecule chaperone rescues the stability and activity of a cancer‐associated variant of NAD(P)H:quinone oxidoreductase 1 in vitro
    Emilia Strandback, Wolf‐Dieter Lienhart, Altijana Hromić‐Jahjefendić, Benjamin M. R. Bourgeois, Anja Högler, Daniel Waltenstorfer, Andreas Winkler, Klaus Zangger, Tobias Madl, Karl F. Gruber et al. · 2019 · FEBS Letters
  62. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population
    Fei Liu, Limei Luo, Yonggang Wei, Wentao Wang, Bo Li, Lvnan Yan, Tianfu Wen · 2012 · Tumor Biology
  63. Proteasome inhibition—a new target for brain tumours
    Fatima Rashid, Maria Victoria Niklison-Chirou · 2019 · Cell Death Discovery
  64. The redox-sensing quinone reductase Lot6p acts as an inducer of yeast apoptosis
    Sonja Sollner, Michael Durchschlag, Kai‐Uwe Fröhlich, Peter Macheroux · 2009 · FEMS Yeast Research
  65. Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells
    Hee-Jin Ahn, Kwangsoo Kim, Kyung-Won Shin, Key‐Hwan Lim, Jin-Ock Kim, Je-Yong Lee, Jiewan Kim, Ji-Hoon Park, Kyung‐Min Yang, Kwang‐Hyun Baek et al. · 2015 · Oncotarget
  66. β-lapachone Activates a Mre11p-Tel1p G1/S Checkpoint in Budding Yeast
    Mauricio Menacho-Márquez, José Ramón Murguía · 2006 · Cell Cycle
  67. Sulforaphane treatment mimics contractile activity-induced mitochondrial adaptations in muscle myotubes
    Sabrina Champsi, David Albert Hood · 2024 · American Journal of Physiology-Cell Physiology
  68. Naturally-Occurring Rare Mutations Cause Mild to Catastrophic Effects in the Multifunctional and Cancer-Associated NQO1 Protein
    Juan Luis Pacheco‐García, Mario Cano‐Muñoz, Isabel Sánchez-Ramos, EDUARDO C. SALIDO, Angel Luis Pey · 2020 · Journal of Personalized Medicine
  69. Association between the p73 gene G4C14-to-A4T14 single nucleotide polymorphism and risk of cervical cancer by high resolution melting and PCR with confronting two-pair primers in a Chinese population
    Haiyan Guo, Shaodi Yang, Lijian Xu, Ding Li, Jianxin Tang, SHUANGSHAUNG WANG, Benjie Wei, Zhengchun Liu · 2016 · Oncology Letters
  70. Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity
    Clare F. Megarity, David J. Timson · 2019 · Bioscience Reports
  71. The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells
    Azmi Yerlikaya, Ertan Kanbur · 2020 · Current Drug Targets
  72. Luteolin Induces Nrf2 Activity in C2C12 Cells: Implications for Muscle Health
    Nicole Böttcher, Frank Suhr, Thomas Pufe, Christoph Jan Wruck, Athanassios Fragoulis · 2025 · International Journal of Molecular Sciences
  73. Effect of CCS on the accumulation of FALS SOD1 mutant-containing aggregates and on mitochondrial translocation of SOD1 mutants: Implication of a free radical hypothesis
    Ha-Kun Kim, Youn Wook Chung, P Boon Chock, Moon B. Yim · 2011 · Archives of Biochemistry and Biophysics
  74. Variable p53/Nrf2 crosstalk contributes to triptolide-induced hepatotoxic process
    Zhenyan Hou, Miao Yan, Huixiang Li, Weida Wang, Shen You, Mingjin Wang, Tingting Du, Hui Gong, Wenqun Li, Lin Guo et al. · 2023 · Toxicology Letters
  75. KCTD5 and Ubiquitin Proteasome Signaling Are Required for Helicobacter pylori Adherence
    Alhejandra Álvarez, Felipe R. Uribe, Jimena Canales, Cristóbal Romero, Andrea Soza, María A. Peña, Marcelo Antonelli, Oscar Almarza, Oscar Cerda, Héctor Toledo · 2017 · Frontiers in Cellular and Infection Microbiology
  76. Degradation of Intrinsically Disordered Proteins by the NADH 26S Proteasome
    Peter Tsvetkov, Nadav Myers, Julia Adler, Yosef Shaul · 2020 · Biomolecules
  77. Anoikis triggers Mdm2-dependent p53 degradation
    Abhijit Ghosh, Tina Chunyuan Chen, Yvonne Lorraine Kapila · 2010 · Molecular and Cellular Biochemistry
  78. Sex-specific role of myostatin signaling in neonatal muscle growth, denervation atrophy, and neuromuscular contractures
    Marianne E. Emmert, Parul Aggarwal, Kritton Shay‐Winkler, Se‐Jin Lee, Qingnian Goh, Roger Cornwall · 2022 · eLife
  79. Effect of naturally-occurring mutations on the stability and function of cancer-associated NQO1: Comparison of experiments and computation
    Juan Luis Pacheco‐García, Matteo Cagiada, Kelly Tienne-Matos, EDUARDO C. SALIDO, Kresten Lindorff‐Larsen, Angel Luis Pey · 2022 · Frontiers in Molecular Biosciences
  80. Lipoperoxide Nanoemulsion as Adjuvant in Cisplatin Cancer Therapy: In Vitro Study on Human Colon Adenocarcinoma DLD-1 Cells
    Stefania Vernazza, Elena Dellacasa, Sara Tirendi, Laura Pastorino, Anna Maria Bassi · 2021 · Nanomaterials
  81. Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells
    Hong Yu, Hong-ying Gao, Hua Guo, Guizhen Wang, Yiqing Yang, Qian Hu, Li-jun Liang, Qun Zhao, Dawei Xie, Yu Rao et al. · 2021 · Acta Pharmacologica Sinica
  82. A single evolutionarily divergent mutation determines the different FAD‐binding affinities of human and rat NQO1 due to site‐specific phosphorylation
    Juan Luis Pacheco‐García, Dmitry S. Loginov, Bruno Rizzuti, Pavla Vaňková, José L. Neira, Daniel Kavan, Noel Mesa‐Torres, Rita Guzzi, Petr Man, Angel Luis Pey · 2021 · FEBS Letters
  83. Different phenotypic outcome due to site-specific phosphorylation in the cancer-associated NQO1 enzyme studied by phosphomimetic mutations
    Juan Luis Pacheco‐García, Ernesto Anoz‐Carbonell, Dmitry S. Loginov, Pavla Vaňková, EDUARDO C. SALIDO, Petr Man, Milagros Medina, Rogelio Palomino‐Morales, Angel Luis Pey · 2022 · Archives of Biochemistry and Biophysics
  84. Research on the effects of rs1800566 C/T polymorphism of NAD(P)H quinone oxidoreductase 1 gene on cancer risk involves analysis of 43,736 cancer cases and 56,173 controls
    Hangsheng Zhou, Hongyuan Wan, Lijie Zhu, Yuanyuan Mi · 2022 · Frontiers in Oncology
  85. Proteasome activation: A novel strategy for targeting undruggable intrinsically disordered proteins
    Qian Yu, Zheng Wang, Yutong Tu, Yu Cao, Huajian Zhu, Jiaan Shao, Rangxiao Zhuang, Yubo Zhou, Jiankang Zhang · 2024 · Bioorganic Chemistry
  86. Timely Activation of Budding Yeast APCCdh1 Involves Degradation of Its Inhibitor, Acm1, by an Unconventional Proteolytic Mechanism
    Michael Melesse, Eunyoung Choi, Hana Hall, Michael J. Walsh, M. Ariel Geer, Mark C. Hall · 2014 · PLoS ONE
  87. Down-regulating NQO1 promotes cellular proliferation in K562 cells via elevating DNA synthesis
    Fei‐Yan Xiao, Zhiping Jiang, Yuan Fang, Fang‐Jiao Zhou, Wei Kuang, Gan Zhou, Xiao-Ping Chen, Rong Liu, Hong‐Hao Zhou, Xielan Zhao et al. · 2020 · Life Sciences
  88. PU.1 Is Degraded in Differentiation of Erythrocytes Through a Proteasome-Dependent Pathway
    Konishi, Yuko, Tominaga, Akira · 2006 · DNA and Cell Biology
  89. Hypertrophic Cardiomyopathy-Associated CRYABR123W Activates Calcineurin, Reduces Calcium Sequestration, and Alters the CRYAB Interactome and the Proteomic Response to Pathological Hypertrophy
    Andres Thorkelsson, Chun Chou, Audrey Tripp, Samia A. Ali, Jonas Galper, Michael T. Chin · 2025 · International Journal of Molecular Sciences
  90. Proteasomal control of transcription factors: mechanisms, regulation and dysregulation
    Fia B. Larsen, Birthe Brandt Kragelund, Kresten Lindorff‐Larsen, Pétur O. Heidarsson, Rasmus Hartmann‐Petersen · 2026 · Cellular and Molecular Life Sciences
  91. Ubiquitin-Independent Degradation and its Implication in Cancer
    Bruce R. Zetter, Ursula Loizides‐Mangold · 2005 · Future Oncology
  92. Isolation and identification of cytoprotective agents from nonpolar extracts of buckwheat flour
    Rong‐ying Qiu, Junru Wang, Kirk L. Parkin · 2014 · Food Research International
  93. IDPs and Protein Degradation in the Cell
    Yosef Shaul, Peter Tsvetkov, Nina Bacher Reuven · 2010 · Wiley eBooks
  94. A 20S proteasome receptor for degradation of intrinsically disordered proteins
    Assaf Biran, Nadav Myers, Julia Adler, Karin Broennimann, Nina Bacher Reuven, Yosef Shaul · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  95. The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells
    Valério Taverniti, Hanna Krynska, Assunta Venuti, Marie‐Laure Straub, Cécilia Sirand, Eugenie Lohmann, Maria Carmen Romero-Medina, Stefano Moro, Alexis Robitaille, Luc Négroni et al. · 2023 · mSphere
  96. Structural dynamics at the active site of the cancer‐associated flavoenzyme NQO1 probed by chemical modification with PMSF
    Alice Grieco, Miguel Ángel Ruiz-Fresneda, Atanasio Gómez‐Mulas, Juan Luis Pacheco‐García, Isabel Quereda‐Moraleda, Angel Luis Pey, Jose Manuel Martin-Garcia · 2023 · FEBS Letters
  97. The intracellular stability of DLC1 is regulated by the 26S proteasome in human hepatocellular carcinoma cell line Hep3B
    Hongwei Luo, Qiu-ping Luo, Ying Yuan, Xiaoying Zhu, Shi-feng Huang, Zhi Peng, Chunli Li, Zong-Gan Huang, Wenli Feng · 2010 · Biochemical and Biophysical Research Communications
  98. Redox state and the sirtuin deacetylases are major factors that regulate the acetylation status of the stress protein NQO1
    David M. Siegel, Peter S. Harris, Cole R. Michel, Rafael de Cabo, Kristofer S. Fritz, David Ross · 2022 · Frontiers in Pharmacology
  99. The ubiquitin-like modifier FAT10 is degraded by the 20S proteasome in vitro but not in cellulo
    Franziska Oliveri, Steffen Johannes Keller, Heike Goebel, Gerardo Omar Alvarez Salinas, Michael Basler · 2023 · Life Science Alliance
  100. Loss of MEG3 contributes to the enhanced migration and invasion in arsenic-induced carcinogenesis through NQO1/FSCN1 pathway.
    Huailu Tu, Zhuo Zhang, Jingxia Li, Sophia Shi, Max Costa · 2023 · PubMed Central